Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Otto

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Hematology/Oncology|January 16, 2015
NK cell-based immunotherapies in Pediatric OncologyKimberly A McDowell, Jacquelyn A Hank, Kenneth B DeSantes, et al.
Transplant Immunology|March 19, 2025
Comprehensive up-to-date analysis on TCRαβ/CD19-depleted hematopoietic stem cell transplantation in pediatric hematological malignanciesHussien Ahmed H Abdelgawad, Heba Aboeldahab, Mohamed Mohamed Belal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolationMario Otto, Raymond C Barfield, Rekha Iyengar, et al.
Stem Cells (Dayton, Ohio)|October 7, 2006
Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiationMario Otto, Xiaohua Chen, William J Martin, et al.
Journal of Materials Chemistry. B|April 19, 2016
Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstructPeifu Jiao, Mario Otto, Qiaohong Geng, et al.
Journal of Materials Chemistry. B|December 15, 2015
Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticlesYaolin Xu, Dana C Baiu, Jennifer A Sherwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastomaMario Otto, Raymond C Barfield, William J Martin, et al.
Nanomedicine (London, England)|October 1, 2015
High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticlesDana C Baiu, Nathan S Artz, Meghan R McElreath, et al.
Leukemia & Lymphoma|January 27, 2021
Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceuticalAnkita Shahi, Gerald E Weiss, Saswati Bhattacharya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
Preclinical Pharmacokinetics and Dosimetry Studies of <sup>124</sup>I/<sup>131</sup>I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft ModelsIan R Marsh, Joseph Grudzinski, Dana C Baiu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|January 16, 2015
NK cell-based immunotherapies in Pediatric OncologyKimberly A McDowell, Jacquelyn A Hank, Kenneth B DeSantes, et al.
Transplant Immunology|March 19, 2025
Comprehensive up-to-date analysis on TCRαβ/CD19-depleted hematopoietic stem cell transplantation in pediatric hematological malignanciesHussien Ahmed H Abdelgawad, Heba Aboeldahab, Mohamed Mohamed Belal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolationMario Otto, Raymond C Barfield, Rekha Iyengar, et al.
Stem Cells (Dayton, Ohio)|October 7, 2006
Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiationMario Otto, Xiaohua Chen, William J Martin, et al.
Journal of Materials Chemistry. B|April 19, 2016
Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstructPeifu Jiao, Mario Otto, Qiaohong Geng, et al.
Journal of Materials Chemistry. B|December 15, 2015
Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticlesYaolin Xu, Dana C Baiu, Jennifer A Sherwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastomaMario Otto, Raymond C Barfield, William J Martin, et al.
Nanomedicine (London, England)|October 1, 2015
High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticlesDana C Baiu, Nathan S Artz, Meghan R McElreath, et al.
Leukemia & Lymphoma|January 27, 2021
Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceuticalAnkita Shahi, Gerald E Weiss, Saswati Bhattacharya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
Preclinical Pharmacokinetics and Dosimetry Studies of <sup>124</sup>I/<sup>131</sup>I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft ModelsIan R Marsh, Joseph Grudzinski, Dana C Baiu, et al.
Pageof 3